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Alternative pre-mRNA splicing is widely used to regulate gene expression by tuning the levels of tissue-specific mRNA
isoforms. Few regulatory mechanisms are understood at the level of combinatorial control despite numerous
sequences, distinct from splice sites, that have been shown to play roles in splicing enhancement or silencing. Here we
use molecular approaches to identify a ternary combination of exonic UAGG and 59-splice-site-proximal GGGG motifs
that functions cooperatively to silence the brain-region-specific CI cassette exon (exon 19) of the glutamate NMDA R1
receptor (GRIN1) transcript. Disruption of three components of the motif pattern converted the CI cassette into a
constitutive exon, while predominant skipping was conferred when the same components were introduced, de novo,
into a heterologous constitutive exon. Predominant exon silencing was directed by the motif pattern in the presence of
six competing exonic splicing enhancers, and this effect was retained after systematically repositioning the two exonic
UAGGs within the CI cassette. In this system, hnRNP A1 was shown to mediate silencing while hnRNP H antagonized
silencing. Genome-wide computational analysis combined with RT-PCR testing showed that a class of skipped human
and mouse exons can be identified by searches that preserve the sequence and spatial configuration of the UAGG and
GGGG motifs. This analysis suggests that the multi-component silencing code may play an important role in the tissue-
specific regulation of the CI cassette exon, and that it may serve more generally as a molecular language to allow for
intricate adjustments and the coordination of splicing patterns from different genes.
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Introduction
Alternative pre-mRNA splicing is a major determinant of
the protein functional diversity underlying human physiol-
ogy, development, and behavior [1]. This process combines
exonic sequences in various arrangements to generate two or
more mRNA transcripts from a single gene. Splicing patterns
are inherently ﬂexible, with variations observed in different
cells and tissues and at different stages of development [2].
Inducible changes in splicing pattern can also occur as a
function of cell excitation in neuronal systems, T cell
activation, heat shock, or cell cycle changes [3,4,5,6]. Thus, a
central problem is to understand the combinatorial mecha-
nisms that adjust splicing patterns in different biological
systems. A related issue is to understand how splicing errors,
including alterations in splicing patterns, arise from in-
herited mutations or polymorphisms and contribute to
human disease [7,8,9].
Splicing decisions occur in the context of the spliceosome,
a highly complex molecular machine containing the small
nuclear ribonucleoprotein particles U1, U2, and U4/U5/U6,
and a host of protein factors [10,11,12]. Spliceosome assembly
occurs in a stepwise fashion to recognize the appropriate
splice sites, to fashion the small-nuclear-ribonucleoprotein-
particle-based catalytic activity, and to couple the splicing
process with transcription, 39 end formation, and nuclear
export. Exon deﬁnition, or recognition of the exon as a unit,
occurs early in spliceosome assembly, and its efﬁciency
depends upon the strengths of the adjacent splice sites, as
well as auxiliary splicing regulatory elements.
RNA control elements, which are distinct from the canon-
ical splice sites, include the positive-acting exonic splicing
enhancers (ESEs) and intronic splicing enhancers, and the
negative-acting exonic splicing silencers (ESSs) and intronic
splicing silencers [8,13,14,15,16,17]. In order to achieve 100%
inclusion of the exon in the processed mRNA, constitutive
exons generally require some combination of ESEs in
addition to the adjacent splice sites. Serine-arginine-rich
(SR) protein factors are important mediators of splicing
enhancement in both constitutive and alternative splicing.
These proteins recognize ESE motifs through their RNA
binding domains, and recruit splicing factors or interact with
splice sites via interactions with their RS domains [18,19,20].
Alternative splicing affects the majority of human protein
coding genes [21,22], but the molecular control mechanisms
are poorly understood. Molecular dissection of a handful of
prototypical alternatively spliced genes has shown that
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Open access, freely available online PLoS BIOLOGYcassette exons are included at a frequency that depends on
their complex arrangement of positive and negative RNA
control elements. It is thought that combinatorial control,
which involves the integrated actions of multiple RNA
control elements and protein regulatory factors, is the basis
of tissue-speciﬁc patterns of splicing. Many protein factors of
the SR protein and heteronuclear ribonucleoprotein
(hnRNP) protein families have been implicated in these
mechanisms, and some of their expression patterns are tissue-
speciﬁc. The polypyrimidine tract binding protein (PTB/
hnRNP I), for example, plays important roles in mechanisms
of negative control important for brain- and muscle-speciﬁc
splicing events. Current evidence indicates that PTB/hnRNP I
takes part in silencing by recognizing RNA elements
containing UCUU and related motifs, and, through protein
oligomerization, blocks recognition of the exon by the
normal splicing machinery [23]. The hnRNP A1 protein has
also been implicated in a variety of cellular and viral splicing
silencing mechanisms through its cooperative recognition of
UAGGG[U/A] and related motifs [24].
The CI cassette exon (exon 19) of the GRIN1 transcript
(NMDA-type glutamate receptor, NR1 subunit) is a valuable
model to study mechanisms of regulation because of its
striking patterns of tissue-speciﬁc splicing and developmental
regulation in the rat brain [25,26]. (Note that the CI exon is
referred to as E21 in these previous studies.) The CI exon is
prominently included in the forebrain, and prominently
skipped in the hindbrain, but the control mechanisms
underlying these patterns are poorly understood. The RNA
binding protein NAPOR/CUGBP2 is thought to positively
regulate this exon since this factor promotes CI cassette exon
inclusion in co-expression assays, and because its tissue-
speciﬁc expression correlates with the spatial distribution of
mRNA transcripts containing the CI exon in rat brain [26]. In
mammals, NMDA-type glutamate receptors are assembled
from GRIN1 (NR1) and GRIN2A (NR2) subunits, and they play
highly important roles impacting learning and memory
functions in the brain. Alternative splicing is used extensively
for the generation of the brain-speciﬁc GRIN1 transcripts,
and CI exon inclusion affects the trafﬁcking of NMDA
receptors to the synapse [27,28].
In many cases tissue-speciﬁc exon inclusion is modulated
by combinations of sequence motifs acting cooperatively or
antagonistically [29]. An understanding of the essential
ingredients for splicing silencing should allow de novo
identiﬁcation of skipped exons from genomic sequence. Here
molecular approaches were used to identify sequences
responsible for silencing the CI cassette exon, and this
analysis was extended using computational methods to
explore the distribution and functional relevance of the
identiﬁed motifs in mammalian genomes. It is a paradox that
the CI cassette exon undergoes predominant exon skipping
in particular regions of the brain, since its adjacent splice
sites match well to consensus patterns. In our previous study,
the downstream intron was shown to play a role in silencing,
but the factors involved were not deﬁned [26].
Here we deﬁne a ternary sequence code—two exonic
UAGGs and a 59-splice-site-proximal GGGG—that imposes
silencing on an inherently strong CI cassette exon. We further
extend this analysis to investigate the roles of hnRNP proteins
and the generality of this type of mechanism genome-wide
using molecular and bioinformatics approaches. The associ-
ation of exon silencing with a UAGG and GGGG motif
pattern in human and mouse exons otherwise unrelated to
the CI cassette supports the generality of this mechanism, and
this is consistent with the demonstrated ﬂexibility in the
spatial positioning of the UAGG components of the code.
Results
A5 9-Splice-Site-Proximal GGGG and Two Exonic UAGG
Motifs Are Required in Combination for Silencing of a
Brain-Region-Specific Exon
The 59 splice site of the CI cassette exon is atypical because
of an adjacent GGGG motif, which is conserved in human, rat,
and mouse GRIN1 genes. GGGG motifs in the ﬁrst ten
nucleotides of human introns are generally infrequent (see
below). In the case of the CI cassette exon, the GGGG motif is
immediately adjacent to the U1 small nuclear RNA comple-
mentary region of the 59 splice site, and the overall
complementarity of the 59 splice site (6 bp) is typical for
mammals (6 to 7 bp), including all of the most highly
conserved positions ( 1t oþ5).
The role of the GGGG motif in splicing silencing of the CI
cassette exon was examined by generating site-directed
mutations in nucleotides þ6, þ7, and þ8 of the intron. These
mutations were designed so as not to disrupt the U1 small
nuclear RNA complementary nucleotides, which include the
last nucleotide of the CI exon and the ﬁrst ﬁve nucleotides of
the adjacent intron. Splicing assays involved transfecting
splicing reporters into non-neuronal mouse myoblasts
(C2C12 cells), followed by measurement of the levels of the
exon-included and exon-skipped products by RT-PCR rela-
tive to the wild-type sequence.
Each mutation in the GGGG motif led to a dramatic
increase in exon inclusion (Figure 1A). The strongest effects
were observed when the GGG at þ6t oþ8 was converted to
CCC (mutation 5m2) or AUA (5m4), which resulted in an
approximately 4-fold increase in exon inclusion, compared to
the wild-type sequence. Even a point mutation (5m9) resulted
in a 3-fold increase in exon inclusion. Thus, the GGGG motif
plays an important role in the silencing mechanism. Addi-
tional sequence changes upstream and downstream of the
GGGG motif had only modest effects on splicing. For
example, mutations 5m1, 5m13, and 5m14 were designed to
test potential RNA secondary structures involving the GGGG
motif and complementary intron sequences. The modest
changes in the splicing pattern resulting from these muta-
tions do not support a signiﬁcant role in splicing for these
hypothetical structures.
Other than the GGGG motif at the 59 splice site, the
sequence of this intronic region is devoid of guanosine-rich
sequences. Strikingly, introduction of a GGG at intron
positions þ40 to þ42 (5m8) resulted in a 5-fold decrease in
exon inclusion. In contrast, two overlapping mutations that
did not generate guanosine-rich motifs had little or no effect
on the splicing pattern (5m11 and 5m12). Thus, in this
context the introduction of a second intronic GGG cluster
can shift the splicing pattern toward nearly complete exon
skipping.
The possibility that sequences within the CI cassette exon
itself might contribute to the silencing mechanism was also
explored. Either a scarcity of ESE sequences within the CI
cassette exon might weaken exon deﬁnition, or the presence
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Exon Silencing by UAGG and GGGG Motifsof exonic ESS sequences might enforce silencing. A model for
the arrangement of ESE motifs in the CI cassette exon was
based on the high-afﬁnity sequence-recognition sites for
known SR family splicing factors (Figure 1B, top). Mutations
were then made in the ASF/SF2 (AGCCCGA, CACCCUG, and
CGUAGGU) and SC35 (CGACCCUA, GGCCUCCA, and
GUCCUCCA) motifs to test predictions of this model,
anticipating that reduced exon inclusion should result from
the disruption of functional ESE motifs.
The results of these experiments show that most of the
mutations decreased exon inclusion, consistent with ESE
function (mutations E1, E2, E3, E4, E5, and E6; Figure 1B). In
contrast, a pair of double point mutations in a UAGG
sequence beginning at position 93 of the exon generated a
substantial increase in exon inclusion, indicative of a
silencing role for this sequence (E8 and E9; Figure 1B). Note
that the overlapping ASF/SF2 motif is disrupted by the E9
mutation, but the E8 mutation generates a different ASF/SF2
motif. An additional six-nucleotide mutation (CAUCGU) that
eliminates the ASF/SF2 motif at this position also resulted in
a strong increase in exon inclusion (K. H. and P. J. G.,
unpublished data). These results show that the position 93
UAGG motif functions in C2C12 cells primarily as a silencer
rather than as part of an ASF/SF2 motif. These results
suggested the possible involvement of the splicing repressor
hnRNP A1 based on the similarity of the UAGG motif to the
hnRNP A1 high-afﬁnity binding sequence UAGGG[A/U]
determined previously by SELEX experiments [30].
A Motif Pattern for Strong Splicing Silencing: Analysis of
Copy Number and Position Effects in Neuronal and Non-
Neuronal Cells
The presence of two natural UAGG motifs in the CI
cassette exon raised the question of how silencing might be
Figure 1. Exonic UAGG and 59 Splice Site GGGG Motifs Are Required in Combination for Silencing of the CI Cassette Exon
(A) A GGGG splicing silencer motif at the 59 splice site. Top: Sequence of the 59 splice site region (59 to 39) with exonic (uppercase) and intronic
(lowercase) nucleotides. Numbering is relative to the ﬁrst nucleotide of the intron. Arrowhead indicates 59 splice site. A predicted SRp40 motif
overlying the last seven bases of the exon is indicated. Engineered mutations and names of splicing reporters are indicated immediately below
the affected nucleotides. Effect of mutations on the pattern of splicing is shown in a 59 to 39 arrangement (gel panel and graph). All splicing
reporter plasmids have a three-exon structure in which CI is the middle exon (in the schematic, vertical bars indicate exons and horizontal lines
indicate introns). Splicing reporter plasmids were expressed in vivo in mouse C2C12 cells, and splicing patterns assayed by radiolabeled RT-PCR
of cellular RNA harvested from the cells. PCR primers are speciﬁc for the ﬂanking exons. Results of multiple experiments are shown graphically
as the average percent of exon included in product (y-axis) for each splicing reporter construct (x-axis).
(B) Analysis of ESE motifs. An exonic UAGG splicing silencer motif overlaps an ASF/SF2 motif. Sequence of the CI exon (59 to 39) is shown, with
engineered mutations (underscored) and names of splicing reporters indicated immediately below the affected nucleotides (bold). Numbering is
relative to the ﬁrst nucleotide of the exon. Predicted ESE motifs for ASF/SF2 and SC35 are highlighted above the exonic sequence as indicated
in brackets. The UAGG motif required for silencing (boxed) is indicated below the overlapping ASF/SF2 motif (asterisk). Effect of mutations on
the in vivo pattern of splicing is shown in a 59 to 39 arrangement (gel panel and graph).
Error bars in (A) and (B) represent standard deviations.
DOI: 10.1371/journal.pbio.0030158.g001
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Exon Silencing by UAGG and GGGG Motifsaffected by changes in the number of exonic UAGGs. The
number and position of UAGG motifs in the CI cassette exon
were altered in the context of the wild-type splicing reporter
(wt0) and the effects tested in neuronal (PC12) and non-
neuronal (C2C12) cell lines (Figure 2). One set of mutations
varied the position of the 59-splice-site-proximal UAGG by
disrupting the original motif at position 93 of the exon, and
by introducing a new UAGG motif at positions 11, 76, and 100
(splicing reporters E10, E11, and E20). These position
variations had small effects on the pattern of splicing, with
exon skipping predominating in both cell lines (Figure 2,
lanes 1–4 and 15–18). The effect of a single UAGG was then
examined at different positions of the exon (splicing
reporters E8, E13, E14, E15, and E21). The resulting splicing
patterns uniformly showed an increase in exon inclusion, and
these effects were essentially independent of position (Figure
2, lanes 5–9 and 19–23). It was also evident that the level of
exon inclusion was higher in C2C12 than in PC12 cells,
suggesting that there may be differences in splicing factors
that mediate or antagonize silencing in the two cell lines.
Nonetheless, each cell line exhibited a similar trend—
stronger exon silencing associated with increased copy
number of exonic UAGGs. Thus, splicing silencing of the CI
cassette exon depends critically on the number of UAGG
motifs in the exon, but less so on their relative positions. To
further test the prediction that the strength of splicing
silencing is linked to the number of UAGGs in the exon, a
third UAGG was introduced at position 11 of the exon
(splicing reporter E18). As a result, the level of exon inclusion
decreased to approximately 0% in both cell lines in agree-
ment with this prediction (lanes 11 and 25).
The role of the 59-splice-site-proximal GGGG motif was
examined independently by generating exons lacking the two
natural UAGG motifs in the presence and absence of the
GGGG motif (splicing reporters E17 and T8, respectively;
Figure 2, lanes 10, 12, 24, 26). The GGGG motif had a small
silencing effect in both cell lines in the absence of the exonic
UAGGs (compare E17 and T8; lanes 10 versus 12, and 24
versus 26). By contrast, silencing was reduced substantially
when the GGGG motif was disrupted by mutation in the
Figure 2. Effect of Number and Position of CI Cassette Exon Splicing Silencer Motifs
Splicing reporters were constructed with variations in the number and position of UAGG and/or GGGG motifs. Three sets of schematics (boxed
at center) illustrate the CI cassette exon and adjacent 59 splice site region with positions of exonic UAGG (black vertical bars) and 59 splice site
GGGG (grey vertical stripe) motifs. Splicing reporter names are indicated at left. Vertical arrowhead indicates 59 splice site. Each splicing
reporter was generated by site-directed mutagenesis from parent plasmid wt0. Natural UAGG positions 51 and 93 represent the starting position
of the motif relative to the ﬁrst base of the exon. Engineered UAGG positions 11, 76, and 100 are also indicated (see schematic in center box at
top). Sequence changes of the mutations are underscored: 11, GUGGﬁUAGG; 51, UAGGﬁAUGG; 76, CCAGﬁUAGG; 93, UAGGﬁGUGG; 100,
UCCAAﬁUAGGC. Representative splicing patterns in PC12 cells (left gel panels) and C2C12 cells (right gel panels) are shown together with
average percent exon inclusion values. The correlation between motif pattern and strength of splicing silencing is summarized (bottom). Exon-
included (double arrowheads) and exon-skipped (single arrowheads) products are indicated.
DOI: 10.1371/journal.pbio.0030158.g002
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Exon Silencing by UAGG and GGGG Motifspresence of intact UAGGs: exon inclusion increased signiﬁ-
cantly in PC12 cells (from 25% to 67%; compare wt0 and D0:
Figure 2, lanes 13 and 14), and a similar trend was observed in
C2C12 cells (from 32% to 87%; Figure 2, lanes 27 and 28).
Note that mutant D0 contains two intact UAGGs, but lacks
the GGGG motif. Thus, the GGGG motif acts cooperatively
with the exonic UAGGs in both of these cell lines. Together
these results show that, for the CI cassette, multiple exonic
UAGGs combined with a 59-splice-site-proximal GGGG
function cooperatively to specify silencing of an otherwise
strong exon.
The 59-Splice-Site-Proximal GGGG Motif Is Involved in
Silencing by hnRNP A1 and Anti-Silencing by hnRNP H
Next we sought to identify protein factors that interact
directly with the UAGG and GGGG motifs in order to guide
empirical tests for their roles in splicing silencing. GTP-
labeled RNA substrates were subjected to UV crosslinking in
HeLa nuclear extracts under in vitro splicing conditions.
These experiments showed pronounced crosslinking to a
protein doublet in the vicinity of 50 kDa for RNA substrates
containing the intact GGGG motif (cs1 and 3h1; Figure 3A,
lanes 1 and 3). By contrast, a point mutation in the GGGG
motif largely disrupts protein binding (cs3 and 3h3; Figure
3A, lanes 2 and 4). Because the apparent molecular weights of
these proteins and the guanosine-rich binding speciﬁcity [31]
suggested the involvement of hnRNP H/H9 and F proteins,
relevant antibodies were obtained for immunoprecipitation
experiments. These results identiﬁed the bottom band of the
doublet as hnRNP F (Figure 3A, lanes 5–7), whereas the upper
band corresponded to hnRNP H/H9 (Figure 3A, lanes 8 and 9).
Although the hnRNP F antibody is highly speciﬁc, the H/H9
antibody crossreacts with hnRNP F, which is 95% identical to
H/H9 at the protein sequence level. Control reactions (Figure
3A, lanes 10 and 11) show the background level precipitated
with preimmune serum (lane 10).
Proteins that interact directly with the exonic UAGG motif
were identiﬁed similarly, except that the RNA substrates
contained a single radioactive label in the middle of the
UAGG. Even with a single radioactive label, multiple proteins
were observed to crosslink to the wild-type substrate, wt3,
under splicing conditions (Figure 3B, lane 4). To examine
hnRNP A1 binding, the SELEX-derived consensus sequence,
A1winner, was also tested in parallel. A low efﬁciency of UV
crosslinking of hnRNP A1 has been observed previously [30].
The A1winner contains two UAGGGA sequences, and was
found to crosslink to hnRNP H/H9 and F, in addition to A1
(Figure 3B, lane 1; data not shown). These results show that
A1 is immunoprecipitated as an approximately 35-kDa
protein from the wt3 sample, as was the case for the
A1winner (Figure 3B, lanes 1–8). A control substrate, mt3,
with a dinucleotide mutation in the UAGG showed little or
no immunoprecipitation of crosslinked A1 (Figure 3B, lanes
9–11). Thus, these results conﬁrm that hnRNP A1 binds
directly to the UAGG motif in the context of the CI cassette
exon sequence.
In order to investigate the functional roles of hnRNPs F, H,
and A1 in the silencing mechanism, each protein was co-
expressed with splicing reporters containing the CI cassette
exon, and effects on the splicing pattern were monitored. For
the wild-type splicing reporter containing an intact GGGG
motif, overexpression of hnRNP F or H was found to enhance
CI exon inclusion relative to the pcDNA control (Figure 3C,
lanes 1–5). These effects were reduced but not eliminated in
the presence of the 5m2 splicing reporter, which lacks the
GGGG motif (Figure 3C, lanes 6–10). These results rule out a
role in silencing of the CI exon for hnRNP F and H, and
instead support an anti-silencing role for these factors.
Next we asked whether the silencing role of the GGGG
motif is mediated through hnRNP A1, since the 59 splice site
of the CI cassette exon is related to the A1 consensus binding
motif (ACG:GUAAGGGGAA [colon deﬁnes 59 splice site]
versus UAGGG[A/U]). These experiments also examined the
effects of portions of the ﬂanking introns, since our previous
study demonstrated a role for the downstream intron in this
silencing mechanism. Chimeric splicing reporters contained
the CI cassette exon and various portions of the ﬂanking
introns inserted between exons 1 and 3 of the GABAA
receptor c2 subunit (Figure 3D). When the complete down-
stream intron was present, co-expression of hnRNP A1
reduced exon inclusion from 78.8% to 29.1%, nearly a 3-
fold effect (Figure 3D, lanes 5 and 6). In this context, the
silencing effect of hnRNP A1 depends upon the intact
downstream intron, since the silencing effect was substan-
tially reduced when most of the downstream intron was
removed (rGcCI-wt0 and rGcCI-up; Figure 3D, lanes 1–4).
The role of the 59 splice site GGGG motif was then examined
in the context of the rGcCI-dn reporter by introducing
mutations 5m2 and 5m4, which destroy the guanosine cluster.
The ability of hnRNP A1 to induce splicing silencing was
reduced signiﬁcantly by these mutations, suggesting that A1 is
involved in mediating the cooperative effects of the GGGG
motif (rGcCI-dn5m2 and rGcCI-dn5m4 Figure 3D, lanes 7–
10).
Combinations of UAGG and GGGG Motifs Are Associated
with cDNA- and EST-Confirmed Skipped Exons in the
Human and Mouse Genomes
We next sought to determine the extent to which the CI
cassette silencing motif pattern is associated with exon
skipping (partial or complete) in the human and mouse
genomes. For this analysis, over 90,000 human and mouse
orthologous exon pairs were divided into two datasets based
on the presence or absence of one or more UAGG motifs at
any position in the exon (but not overlapping the splice sites)
and a GGGG motif within bases 3–10 of the adjacent
downstream intron (Figure 4). The percentage of alternatively
spliced (skipped) exons in each of these datasets was then
determined by use of large-scale, high-stringency alignments
of available cDNAs and ESTs to the corresponding genomic
loci (see Materials and Methods). If the motif pattern
functions generally in splicing silencing, the frequency of
exon skipping should be higher in the group of exons
containing the UAGG and GGGG motif pattern, compared to
those without.
In these searches we considered exons of typical size ( 250
bases), and we required each component of the motif pattern
to be conserved in sequence and position in the human and
mouse orthologous exons. Using these stringent criteria, 16
exons (0.018%) contained the motif pattern, and of these,
three were conﬁrmed skipped exons (18.75%). The remaining
90,175 exons (99.98%) lacked the conserved motif pattern,
and of these, 4,173 (4.63%) were conﬁrmed skipped exons.
The difference in the percentage of skipped exons in these
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Exon Silencing by UAGG and GGGG Motifstwo datasets was signiﬁcant (p , 0.05). When exon length was
not constrained, the fraction of skipped exons with the motifs
was slightly lower (15.8%), but still signiﬁcant (p , 0.05).
When this analysis was repeated without requiring conserva-
tion of the motif pattern, 227 exons (0.24%) contained the
motif pattern, and of these, 18 (7.9%) were conﬁrmed
skipped exons (p , 0.05). The remaining 96,292 exons
(99.76%) lacked the motif pattern, and of these 4,441
(4.61%) were conﬁrmed skipped exons.
Variations of the CI cassette motif pattern were also
analyzed. The reciprocal pattern, one or more GGGG motifs
in the exon and a UAGG motif in bases 3–10 of the intron,
also showed enrichment for conﬁrmed skipped exons (8.4%)
compared to those without this pattern (4.6%) (p , 0.001).
Figure 3. Identification and Functional Roles of Protein Factors That Bind to GGGG and UAGG Motifs
(A) Detection of protein binding to the 59 splice site GGGG motif by UV crosslinking in HeLa nuclear extract. Wild-type (cs1 and 3h1) and
mutant (cs3 and 3h3) RNA substrates were internally labeled at guanosine nucleotides; mutations are underscored. Pattern of UV crosslinking is
shown following RNase digestion and SDS-PAGE (lanes 1–4). Immunoprecipitation reactions (lanes 5–11) contained the 3h1 substrate together
with antibody speciﬁc for hnRNP F or H/H9; control samples contained preimmune rabbit serum. Gel panel shows the pellet (P), supernatant (S),
and input (I) of the immunoprecipitation reactions following SDS-PAGE. The positions of hnRNP H/H9 and F (arrowheads) and protein
molecular weight standards (in kilodaltons) are indicated. The hnRNP F and H/H9 antibodies were a gift of C. Milcarek.
(B) UV crosslinking of exonic position 93 UAGG motif in HeLa nuclear extract. RNA substrates were prepared with a single radiolabeled
nucleotide as indicated by the asterisk; sequences are shown (bottom). The wild-type (wt3) and mutant (mt3) substrates are identical except for
the underscored mutation. The A1winner substrate corresponds to the high-afﬁnity hnRNP A1 binding sequence previously identiﬁed by
SELEX. The position of hnRNP A1 is indicated (arrowhead). Monoclonal antibody 9H10 was a gift of G. Dreyfuss.
(C) Exon inclusion is enhanced by co-expression of hnRNP F or H. Gel panel shows splicing pattern resulting from co-transfection of wild-type
(wt) or mutant (5m2) splicing reporter with hnRNP F or H expression plasmid; splicing reporters are identical to those shown in Figure 1A.
Control samples were transfected with empty vector; grey wedge indicates two levels (4 and 6 lg) of protein expression plasmid. Arrowhead
indicates 59 splice site. For immunoblot veriﬁcation of transfected protein expression (bottom), nuclear extracts from transfected cells were
separated by SDS-PAGE, transferred to nylon membrane, and developed with an antibody speciﬁc for the Xpress tag at the N-terminus of each
pcDNA–protein sample. Raw percent exon inclusion values are shown below gel image.
(D) Silencing effect of hnRNP A1 requires the intact 59 splice site GGGG motif and full-length downstream intron. Structures of chimeric
splicing reporters are shown in which the CI cassette exon and intron ﬂanks were introduced into an unrelated splicing reporter containing
sequences from the GABAA receptor c2 transcript: rGcCI-wt0 (both introns truncated), -up (full-length upstream intron, truncated downstream
intron), and -dn (truncated upstream intron, full-length downstream intron). Numbers above indicate length of each intron segment in
nucleotides. Arrowhead indicates 59 splice site. The splicing reporters rGcCI-dn5m2 and -dn5m4 contain the full-length downstream intron with
59 splice site mutations of Figure 1A. Gel panel shows splicing pattern resulting from co-transfection of splicing reporter with hnRNP A1
expression plasmid or vector control. Immunoblot veriﬁcation of transfected protein expression (bottom) is as described in (C).
DOI: 10.1371/journal.pbio.0030158.g003
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Exon Silencing by UAGG and GGGG MotifsMoreover, the occurrence of a 59 splice site GGGG by itself
was found to be associated with exon skipping: exons
containing the GGGG motif in bases 3–10 of the intron but
lacking UAGG and GGGG within the exon showed a
signiﬁcantly higher rate of exon skipping (7.8%) compared
to those without the GGGG intronic motif (4.6%) (p , 0.001).
Moving the position of the GGGG motif slightly downstream
to bases 11–20 of the intron reduced the fraction of skipped
exons observed to background levels (4.6%). Taken together,
these data suggest that the close proximity (or overlap) of the
GGGG motif to the 59 splice site may be generally important
in silencing, perhaps by limiting binding of U1 or U6 small
nuclear ribonucleoprotein particles.
Underrepresentation of UAGG in Constitutive Exons, and
Overrepresentation in Skipped Exons
Underrepresentation of UAGG in constitutively spliced
exons and overrepresentation in skipped exons would be
expected if this motif frequently plays a role in splicing
silencing. To test this idea, approximately 5,000 known
human cDNAs were downloaded from Ensembl (www.ensem-
bl.org), and those containing a full-length ORF were shufﬂed
50 times using the program CodonShufﬂe. CodonShufﬂe
randomizes the nucleotide sequence by swapping synono-
mous codons, preserving the encoded amino acid sequence,
codon usage, and base composition of the native mRNA [32].
Consequently, the program controls for constraints on the
protein coding function of the mRNA, and for constraints on
codon usage. Since the ORF is preserved by this type of
shufﬂing, codon arrangements forbid the UAG portion of the
UAGG motif to occur in-frame. The occurrence of UAGG was
reduced by 1.5-fold in authentic coding sequences as
compared to CodonShufﬂed control sequences (p , 0.001).
Thus, the correlation of the motif with exon skipping is
statistically signiﬁcant, and there is modest selection against
UAGG sequences for constitutive exons. Next we asked
whether UAGG is overrepresented in skipped human exons.
As expected, both UAGG and GGGG were found to be
signiﬁcantly overrepresented in skipped exons as compared
to constitutive exons in human (v
2 = 436 and 87,
respectively; p , 10
 5 for both).
More rigorously, when all possible 5-mers were examined
for overrepresentation in orthologous exons that are skipped
in both human and mouse, a signiﬁcant enrichment for
UAGGC and UAGGG motifs was found (v
2 = 15 and 13,
respectively; p , 10
 4) compared to orthologous pairs of
constitutive exons. UAGGA and UAGGU were not signiﬁ-
cantly overrepresented, but this may be explained by the
small dataset used for the analysis (approximately 240 exons),
or to functional overlap with ESE sequences. Nonetheless, the
appearance of the UAGG motif in two 5-mers indicates the
importance of the motif in conserved skipped exons. Over-
representation of UAGG in skipped exons has also been
found for mRNAs expressed in brain and testes, which are
enriched for regulated splicing events [33].
Identification of Skipped Exons with Conserved UAGG and
GGGG Motif Patterns across the Human and Mouse
Genomes
To identify exons unrelated to the CI cassette that might be
silenced by a similar motif conﬁguration, we focused in more
detail on the UAGG and GGGG motif pattern by searching
for these motifs singly and in combination in the database of
approximately 96,000 human and mouse orthologous exons.
Exons containing a GGGG in bases 3–10 of the intron and
one or more exonic UAGGs were identiﬁed in the human and
mouse subsets of the database and at the intersection of these
datasets. These data are presented as Venn diagrams, and
speciﬁc examples selected from the intersection dataset are
shown to illustrate the motif patterns that are conserved in
human and mouse orthologous exons (Figure 5). We included
in the intersection dataset only exons in which the motif
Figure 4. Computational Analysis of UAGG and GGGG Motif Patterns
Reveals Association with Exon Skipping Genome-Wide
At the top is a ﬂow chart for the computational analysis used to
illustrate the procedure used to identify human exons with and
without the CI cassette silencer motif pattern ( 1 exonic UAGG and
a5 9-splice-site-proximal GGGG), followed by the determination of
the percentage of conﬁrmed skipped exons in each group. The
reciprocal pattern ( 1 exonic GGGG and a 59 splice site UAGG) and
related variants were analyzed for comparison as indicated in the
graph and table. The graph (middle) shows exons with the motif
pattern on the left and the remaining exons without the pattern (w/o)
on the right; x-axis, 59 splice site motif; y-axis, percent conﬁrmed
skipped exons; z-axis, exonic motif. Conﬁrmed skipped exons were
deﬁned as those skipping events supported by 20 or more individual
cDNA and/or EST entries. Exonic motifs were allowed at any position
within the exon, but not overlapping the splice sites, and the 59 splice
site motif was restricted to bases 3–10 of the intron. Only exons of
250 nucleotides or fewer were considered. The table (bottom) shows,
for each motif pattern, the percentage of conﬁrmed skipped exons
within that group (as shown in the graph) and the number of exons in
the group (in parentheses). The CI cassette silencer motif pattern is
boxed.
DOI: 10.1371/journal.pbio.0030158.g004
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Exon Silencing by UAGG and GGGG Motifspattern is conserved in sequence and position in the human
and mouse orthologous exons.
As expected, the CI cassette exon of the GRIN1 gene was
found in all three of the overlap datasets. Of the 19 exons
containing the motif pattern in the intersection dataset, 16
exons of 250 or fewer bases in length were considered for
further study based on the observation that skipping of
longer exons is quite rare [34]. This dataset contained the
genes for two well known splicing factors, hnRNP H1 and H3
(HNRPH1 and HNRPH3). Although human hnRNP H1
contains 14 exons and H3 contains ten exons, the UAGG
and GGGG motif pattern was found associated with a single
exon in each of these genes. As hnRNP H proteins are known
to bind to guanosine-rich sequences, the presence of a
conserved GGGG motif in the 59 splice sites of these hnRNP
H exons suggests the possibility of autoregulation at the level
of splicing.
The hnRNP H exons and additional candidates in the
intersection dataset (total of 12) were selected for exper-
imental analysis of splicing patterns by RT-PCR, and to
investigate the tissue speciﬁcity of the splicing patterns in
human tissues (Figure 6; Table 1). The CI cassette exon was
included in the analysis as a positive control (GRIN1).
Skipping of the candidate exons for both human HNRPH1
and HNRPH3 was conﬁrmed in several tissues. Exon skipping
was also conﬁrmed for candidate exons of UTRN and an
uncharacterized hypothalamus-expressed gene, and tissue-
speciﬁc exon skipping was evident for HNRPH1 exon 5,
HNRPH3 exon 3, and UTRN exon 5. To our knowledge, these
tissue-speciﬁc patterns have not been characterized previ-
ously. The results of Figure 6 were conﬁrmed by DNA
sequence analysis of the gel-puriﬁed products of the RT-PCR
reactions. Although the candidate exon in the ANXA8 gene
was not experimentally validated in our analysis, EST and
mRNA evidence conﬁrms that the exon is skipped in cDNA
libraries derived from choriocarcinomas (Table 1). An
important caveat is that the true number of skipped exons
Figure 5. Genome-Wide Identification of Exons with UAGG and GGGG
Silencing Motifs
A database of 96,089 orthologous human and mouse exon pairs was
searched for TAGG located anywhere in the exon and GGGG in bases
3–10 of the intron. Venn diagrams indicate the number of exons
containing either or both sequence motifs in the human subset and
the mouse subset of the database. The number of exons (19) in which
UAGG and GGGG silencer motifs are conserved in orthologous
human and mouse exons is also shown (intersection). The motif
patterns are shown in the context of the exon (uppercase) and 59
splice site region (lowercase) for 12 examples from the intersection
dataset (human sequences are shown). Colon indicates 59 splice site.
The conserved TAGG and GGGG motifs are highlighted in red to
illustrate variations in their positions. Gene name (HUGO ID) and
exon number within the gene are indicated at far right. For one
uncharacterized transcript, the GenBank accession is given instead
(NM_018469_8).
DOI: 10.1371/journal.pbio.0030158.g005
Figure 6. RT-PCR Confirmation of Exon Skipping Patterns in Human
Tissues
Eleven orthologous exons ( 250 nucleotides in length) were selected
from the analysis of Figure 5 for RT-PCR analysis in a panel of eight
human tissues. These exons are derived from the intersection dataset,
in which conserved TAGG and GGGG motifs are present in
combination in the human and mouse orthologous exons. Additional
cDNA and EST evidence for these skipping events are summarized in
Table 1. Speciﬁc primer pairs were designed for each test exon to
amplify the exon-included (double arrowhead) and exon-skipped
(single arrowhead) products by RT-PCR. Each gel panel shows the
products of reactions for a single test exon resolved on agarose gels in
the arrangement given in the inset. Gene name, exon number, and
Ensembl number (in parentheses) are provided above each gel panel.
The far left and far right lanes of each gel panel contain DNA
molecular weight markers.
DOI: 10.1371/journal.pbio.0030158.g006
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Exon Silencing by UAGG and GGGG Motifscould be signiﬁcantly higher than that conﬁrmed by RT-PCR
because our sampling of human tissues in these experiments
was not exhaustive.
The mouse orthologs of HNRPH1 exon 5 and HNRPH3
exon 3 were chosen for further analysis of their splicing
patterns (Figure 7, ‘‘1 TAGGþGGGG exons’’). These splicing
patterns were determined using RNA derived from mouse
heart and brain tissue, as well as from the mouse C2C12 cell
line. For each RNA sample, radioactive RT-PCR reactions
were performed for a set of three serial dilutions of the input
RNA. Good consistency in the percent exon inclusion values
for each set of serial dilutions was evident. Sequence
alignments showed that exon 3 of both the human and
mouse HNRPH3 genes contained an additional exonic GGGG
motif not found in the orthologous HNRPH1 exon 5
sequences (Figure 7, bottom), which might explain the higher
rate of exon skipping observed. HNRPH1 exon 8 and b-actin
exon 2 served as control exons, since these exons do not
contain UAGG or GGGG motifs (Figure 7, ‘‘0 TAGG, 0 GGGG
exons’’). As expected, the ‘‘0 TAGG, 0 GGGG’’ control exons
showed 100% exon inclusion in each case.
The observation that multiple UAGGs are associated with
an increased strength of splicing silencing of the CI cassette
exon (see Figure 2) prompted us to examine several exons
with these characteristics that were identiﬁed in our searches.
From the dataset of 213 human exons containing UAGG and
GGGG, 13 exons with two or more UAGGs were identiﬁed,
and from the dataset of 200 mouse exons containing UAGG
Figure 7. Analysis of Splicing Patterns in Mouse Tissues for Variations in the Number of Exonic UAGGs
Splicing patterns were determined by radiolabeled RT-PCR for selected mouse exons. Control reactions include b-actin exon 2 and HNRPH1
exon 8, which were selected because they lack the silencing motifs studied (‘‘0 TAGG, 0 GGGG exons’’). HNRPH1 exon 5 and HNRPH3 exon 3 are
representative of the one TAGG plus GGGG motif pattern (‘‘1 TAGGþGGGG exons’’). Hp1bp3 exon 2, GRIN1 CI cassette exon, and NCOA2 exon
13 are examples of tissue-speciﬁc exon skipping associated with the two TAGG plus GGGG motif pattern (‘‘2 TAGG þ GGGG exons’’). MEN1
exon 8 is also shown. Each gel panel shows splicing patterns tested in RNA samples from mouse heart and brain tissue and mouse C2C12 cells.
Gene name, exon number, and Ensembl gene ID (in parentheses) are provided above each gel panel. Curly brackets point to the average percent
exon inclusion and standard deviation for each set of serial dilutions; raw values are given immediately below each lane. Sequence alignments
(bottom left) of the corresponding human and mouse orthologs illustrate the patterns of silencer motifs (orange). Bold indicates an additional
exonic GGGG motif.
DOI: 10.1371/journal.pbio.0030158.g007
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Exon Silencing by UAGG and GGGG MotifsTable 1. Human and Mouse Orthologous Exons Containing TAGG and GGGG Motif Patterns
Dataset Entry Ensembl
ID and
Exon
Number
a
HUGO ID or
GenBank
Accession
Number
Exon
Length
(bp)
Number
of TAGG
Motifs
59 Splice
Site Sequence
b
RT-PCR
Analysis
of Exon
Skipping
(This Study)
cDNA and/or EST
Evidence for Exon
Skipping
c
Intersection
dataset
1 158195_4
028868_4
WASF2 118 1
1
AGGgtgaggggaa
AGGgtgaggggaa
Not skipped —
2 169045_5
007850_5
HNRPH1 139 1
1
CAGgtggggatgg
CAGgtggggatgg
Skipped AW579178, and
many others
3 096746_3
020069_2
HNRPH3 139 1
1
CAGgtggggatgg
CAGgtggggatgg
Skipped BE747312, BM916242,
BQ882744, AW878310
4 176884_1
9026959_19
GRIN1 111 2
2
ACGgtaaggggga
ACGgtaaggggaa
Skipped See GRIN1 under
human and
mouse subsets
5 136044_8
020263_8
NM_018171, DIP13BETA 147 1
1
CAGgtaggggagt
CAGgtaggggatg
Not skipped —
6 158865_8
030769_9
NM_052944, KST1 81 1
1
ACAgtaagtgggg
ACAgtaagtgggg
Not skipped —
7 168453_3
022096_3
HR 793 1
3
AAGgtaagggggc
GAGgtaagggggt
ND BX341278
8 068400_2
031153_13
GRIPAP1 96 1
1
AAGgtaggggaac
AAGgtggggcatc
ND —
9 136478_8
040548_8
NM_018469, uncharacterized 133 1
1
AGGgtaaggggct
AGGgtaaggggct
Skipped —
10 108592_1
7020706_18
FTSJ3 100 1
1
CCGgtaaaggggc
CCGgtaaggggca
Not skipped —
11 152818_5
019820_6
UTRN 93 1
1
CAGgtggggaaat
CAGgtggggacct
Skipped —
12 158887_4
005678_4
MPZ ENST00000289928 136 1
1
CAGgtaaggggcg
CAGgtaaggggcg
Not skipped —
13 181045_5
039908_6
SCL26A11 143 1
1
CAGgtgaggggcc
CAGgtgaggggac
Not skipped —
14 147255_1
6031111_15
IGSF1 288 1
1
CAGgtaaggggaa
CTGgtaaggggat
ND —
15 173957_7
037336_6
No description 91 1
1
CAGgtatggggtt
CAGgtatgggggt
ND —
16 106404_2
001739_2
CLDN15 165 1
1
CCGgtaactgggg
CTGgtaatggggg
ND BU164601, AJ245738
17 150165_4
021950_5
ANXA8 91 1
1
AAGgtaaggggtg
AAGgtaaggggtt
ND BC008813, BE902538,
BE902353, BE900246
18 179593_2
020891_2
ALOX15B 220 1
1
CAGgtgaggggcg
CAGgtgaggggac
ND —
19 165816_1
1025082_12
NA 552 2
1
GAGgtgagtgggg
TGAgtggggataa
ND —
Human
subset
h1 176884_19 GRIN1 111 2 ACGgtaaggggga Skipped L13266, AF015730,
L05666, L13267,
AW900783
h2 097054_10 ABCA4 117 2 AGAgtaaggggg Not skipped —
h3 140396_13 NCOA2 207 2 CAGgtaaggggtc Skipped —
h4 099308_21 O60307 245 2 CTGgtaagtgggg Not skipped —
h5 135709_2 Y513_HUMAN 501 2 AGGgtaaggggcc ND —
h6 165816_11 ENST00000298715 552 2 GAGgtgagtgggg ND —
h7 130283_7 LASS1 637 2 GCGgtgagtgggg ND —
h8 007565_3 DAXX 832 2 CAGgtagggggtt ND —
h9 185133_2 PIB5PA 1,166 2 CCGgtgagggggcN D —
h10 111077_18 TENC1 1,212 3 CAGgtgaggggca ND —
h11 142102_4 Q8TEG9 1,418 2 CAGgtgaggggac ND —
h12 135835_5 Q9HCF8 1,556 2 ATGgtaaggggct ND —
h13 138080_4 EMILIN1 1,929 2 CTGgtgaggggac ND —
Mouse
subset
m1 026959_19 GRIN1 111 2 ACGgtaaggggaa Skipped CD363997
m2 023938_18 No description 123 2 GAGgtcaggggcc ND —
m3 024947_8 MEN1_MOUSE 165 2 CAGgtgagagggg Skipped BC036287
m4 026791_8 GRTR8_MOUSE 171 2 CTGgtaaagggga ND BY347810, BY349516
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Exon Silencing by UAGG and GGGG Motifsand GGGG, 12 exons with two or more UAGGs were
identiﬁed (Table 1). Exons within these datasets that had
lengths typical for internal coding exons ( 250 bases) were
chosen for RT-PCR analysis of their splicing patterns. RNA
derived from mouse heart and brain and C2C12 cells
conﬁrmed the skipping of Hp1bp3 exon 2 and NCOA2 exon
13 and trace levels of skipping for MEN1 exon 8 (see Figure 7).
Additional cDNA evidence was found in the databases in
support of these splicing patterns (Table 1). In the case of
Hp1bp3, sequence alignments showed that two TAGGs and the
59 splice site GGGG motif were conserved in the human and
mouse orthologs, but these exons were not found in the
intersection dataset of Figure 5 because the human exon
corresponds to the ﬁrst exon in the transcript, and
consequently was not annotated as an internal exon in the
Ensembl dataset. Sequence alignments for the more weakly
skipped exons, NCOA2 exon 13 and MEN1 exon 8, showed
that one or more segments of the motif pattern was imperfect
in each set of orthologs (see Figure 7, bottom).
Generality of the UAGG and GGGG Motif Pattern for Exon
Silencing and Differential Regulation by hnRNP Proteins
To test whether the silencing motif pattern identiﬁed
above for the CI cassette exon is sufﬁcient for exon silencing
in vivo, this pattern was introduced into the middle exon of a
heterologous splicing reporter, SIRT1 (Figure 8). This middle
exon corresponds to the constitutively spliced exon 6 of the
human SIRT1 gene, and lacks any features of the silencing
motif pattern to be examined. In these experiments the
generality of the motif pattern, as well as the regulatory roles
of hnRNP A1 and H were tested. When the GGGG motif was
introduced by itself at intron positions 6–9 or 8–11 of the
SIRT1 splicing reporter (substrates SIRT1-G6–9 and SIRT1-
G8–11, respectively), no change in the splicing pattern was
observed relative to the parent substrate SIRT1 (Figure 8,
lanes 1, 4, and 7). These results indicate that in the SIRT1
context, the GGGG motif alone is not sufﬁcient to induce
exon skipping. However, when two UAGGs were introduced
into the middle exon (ESS19), the splicing pattern was shifted
substantially, from 100% to 29% exon inclusion (Figure 8,
lane 10). When the GGGG motif was subsequently introduced
into the ESS19 substrate at intron positions 6–9 (ESS19-G6–
9), exon inclusion was further reduced to 18% (Figure 8, lane
13), showing the combined effects of the motif pattern. In this
context, the effect of the intronic GGGG motif was position
dependent, since no additional silencing was observed when
the GGGG was moved to positions 8–11 of the intron (ESS19-
G8–11).
Based on the effects of hnRNP A1 and hnRNP H on the
level of CI cassette exon inclusion described above (see Figure
3), we also tested the effects of these factors with the new
splicing reporter substrates in co-expression assays. Relative
to the vector backbone controls, the co-expression of hnRNP
A1 down-regulated exon inclusion, consistent with the
presence of the complete silencing motif pattern or exonic
UAGGs, and co-expression of hnRNP H had the opposite
effect (see Figure 8, lanes 10–18). The differential effects of
hnRNP A1 and H were both dependent upon the presence of
exonic UAGGs, since no change in the splicing pattern was
observed for substrates SIRT1, SIRT1-G6–9, or SIRT1-G8–11
(see Figure 8, lanes 1–9). Interestingly, these results suggest
that hnRNP H can exert its anti-silencing effect through the
exonic UAGGs.
To further investigate the generality of exon silencing by
UAGG and GGGG motifs, we examined a subset of the exons
identiﬁed by bioinformatics to assess their splicing patterns
and sensitivity to regulation by hnRNP A1 and hnRNP H in
the SIRT1 heterologous context. Exons containing the
silencing motif pattern should be skipped exons, and
regulation by these splicing factors would generally be
expected for exons that contain the silencing motif pattern.
For the convenience of testing new exons in this context, the
SIRT1 splicing reporter was modiﬁed to introduce restriction
sites 12 nucleotides upstream and 12 nucleotides downstream
of the middle exon. Test exons with 12 nucleotides of ﬂanking
intron on each side were then cloned from mouse genomic
DNA and inserted in place of the SIRT1 exon 6 between the
restriction sites (Figure 9). As controls, the middle exon of the
SIRT1 splicing reporter and the middle exon of ESS19 were
reinserted in this context to generate new splicing reporters
identical to those tested above except for the added
Table 1. Continued
Dataset Entry Ensembl
ID and
Exon
Number
a
HUGO ID or
GenBank
Accession
Number
Exon
Length
(bp)
Number
of TAGG
Motifs
59 Splice
Site Sequence
b
RT-PCR
Analysis
of Exon
Skipping
(This Study)
cDNA and/or
EST Evidence
for Exon Skipping
c
m5 028759_2 Hp1bp3 198 3 GAGgtaggggctg Skipped AK075725, AK043260
m6 005886_13 NCOA2 207 2 CAGgtaagggctc Skipped BC053387
m7 007021_2 NM_011522 238 2 CAGgtgggcgggg Not skipped —
m8 015852_2 NM_030707 208 2 AAGgtaggggact ND —
m9 024112_9 CCAH_MOUSE 440 2 CAGgtaggggtgt ND —
m10 028782_26 NM_173071 620 2 GAGgtgaggggct ND —
m11 022096_4 HAIR_MOUSE 781 2 GAGgtaagggggtN D —
m12 052325_5 MAPB_MOUSE 6,490 2 CAGgtaggtgggg ND —
Entries 1–19 correspond to the intersection dataset of Figure 5A, with the human exon listed above the mouse exon. The human subset, h1–h13, and mouse subset, m1–m12, are also shown.
a The Ensembl ID prefixes are ENSG00000- for human and ENSMUSG00000- for mouse.
b Uppercase indicates exonic and lowercase indicates intronic nucleotides.
c Sources: http://genome.ucsc.edu and http://www.ncbi.nlm.nih.gov/.ND, not determined.
DOI: 10.1371/journal.pbio.0030158.t001
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Exon Silencing by UAGG and GGGG Motifsrestriction sites. The splicing patterns of these modiﬁed
substrates, SIRT1a and ESS19a, were found to be essentially
identical to those of SIRT1 and ESS19 shown above, which
shows that the restriction sites have no effect on the splicing
pattern in these assays.
Next we replaced the test exon of SIRT1a with the CI
cassette exon of the rat GRIN1 (GRIN1_CI), exon 8 of MEN1
(MEN1_8), and exon 2 of Hp1bp3 (Hp1bp3_2). In the absence
of protein co-expression, exon skipping was observed in
every case, although the extent of skipping varied over a wide
range (Figure 9, ‘‘Control [vbb]’’). For the CI cassette exon,
hnRNP A1 induced 2.7-fold more skipping, whereas hnRNP H
induced 3.2-fold more exon inclusion compared to the
control sample (Figure 9, compare lanes 3, 8, and 13). Co-
expression of hnRNP H increased the inclusion of exon 2 of
Hp1bp3 by a factor of 7.4, but no effects of hnRNP A1 were
observed (Figure 9, lanes 5, 10, and 15). The latter may have
been precluded by the extreme skipping pattern of this exon
(0.8% inclusion), which contains three exonic UAGG motifs
and a GGGG motif in the 59 splice site. Thus, for these three
exons, the regulation mediated by these hnRNP proteins is
speciﬁed locally—that is, by sequences limited to the exon
and adjacent splice sites. We cannot rule out the possible
contributing roles of unknown sequence control elements in
splicing silencing. However, sequence alignments show that
these exons are highly diverse, and lack shared sequences
longer than a few bases.
Co-expression of hnRNP A1 and hnRNP H was also
observed to regulate exon 8 of MEN1, but with different
results. Whereas exon skipping decreased as expected in the
presence of hnRNP A1 (74% to 57% exon inclusion), exon
skipping decreased to an even greater extent in the presence
of hnRNP H (43% exon inclusion), indicating that both of
these factors can silence the exon (Figure 9, lanes 4, 9, and 14).
Because the MEN1 exon contains two guanosine-rich ASF/SF2
motifs, 59-GGGAGGA39 and 59-AGGAGGG-39, capable of
binding hnRNP H, the observed silencing effect of hnRNP H
in this case is not surprising, and is likely explained by the
disruption of exon enhancement.
Finally, the results observed for the ESS19 splicing reporter
prompted another computational search to determine
whether exon skipping is associated with two or more exonic
UAGGs genome-wide. Similar to the analysis of Figure 4,
exons containing two or more conserved UAGGs were
identiﬁed from a large database (.94,000) of human and
mouse exons and the cDNA/EST-conﬁrmed skipped exons in
that group were determined. From this analysis 163 human
exons were found to contain two or more exonic UAGGs that
are conserved in sequence and position in the orthologous
mouse exons, and 16 of these (9.8%) were conﬁrmed skipped
exons (Figure 10). This was a signiﬁcant enrichment of exon
skipping (p , 0.002) compared to the remaining exons
(90,028) lacking UAGGs, of which 4,160 (4.6%) were con-
ﬁrmed skipped exons. When the analysis was repeated for a
single UAGG in the exon, a larger number of exons was
identiﬁed (3,602), but a smaller percentage of conﬁrmed
skipped exons, 229 (6.4%), was associated with this group (p ,
0.002). The list of 16 human exons with two or more
conserved UAGGs and transcript evidence for skipping is
shown in Figure 10, since these are novel candidates for
alternative splicing regulation. Of particular interest are
Elongator protein 2, NCOA2, Pumilio homolog 2, and RNA
binding protein S1, which are implicated in RNA metabolism.
Discussion
A Combinatorial Code for Exon Silencing
Here we use molecular approaches to deﬁne a ternary
combination of UAGG and GGGG motifs required for
silencing the GRIN1 CI cassette exon, and show that a class
of skipped exons in the human and mouse genomes can be
identiﬁed through bioinformatics searches that maintain the
sequence and spatial conﬁguration of the silencing motifs.
We also illustrate, using the CI cassette model system, how the
combined sequence motifs work cooperatively to determine
the strength of exon silencing, with similar trends in neuronal
and non-neuronal cell types. While a single exonic UAGG or
59-splice-site-proximal GGGG motif speciﬁes weak exon
skipping, multiple UAGGs in the exon together with the
GGGG motif at the 59 splice site speciﬁes predominant exon
Figure 8. Analysis of UAGG and GGGG Motif Pattern in a Heterologous
Context and Effects of hnRNP A1 and H Co-Expression
At the top is a schematic of the heterologous splicing reporter SIRT1
(pZW8) that contains exon 6 of the human SIRT1 gene and ﬂanking
intron sequences as described previously [17]. The intron/exon
lengths (in nucleotides) are as follows: exon 1, 308; intron 1, 340;
exon 2, 95; intron 2, 287; and exon 3, 436. The silencing motif pattern
was introduced sequentially into the middle exon and adjacent 59
splice site region as highlighted in red. GGGG mutations were
introduced by site-directed mutagenesis at positions 6–9 or 8–11 of
the second intron. Exonic UAGG motifs were introduced into the
middle exon by replacing a HindIII-KpnI restriction fragment
AAGCTTTCGAATTCGGTACC, with AAGCTTGTTAGGTATAGG-
TACC (restriction sites are underscored) as described [17]. The
percent exon inclusion values (average of three repeats) were
determined from co-expression assays with vector backbone (vbb)
or with a 1:4 ratio of hnRNP A1 or H expression plasmid (same as
experiment of Figure 3). Below are shown splicing assays following
expression in C2C12 cells in the absence and presence of hnRNP A1
(‘‘A1’’ lanes) or hnRNP H (‘‘H’’ lanes) protein expression vector.
Control reactions contained vector backbone plasmid (‘‘ ’’ lanes).
Exon-included (double arrowheads) and exon-skipped (single arrow-
heads) products are indicated.
DOI: 10.1371/journal.pbio.0030158.g008
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Exon Silencing by UAGG and GGGG Motifsskipping (see Figure 2). This conclusion is strengthened by the
complementary results observed when these RNA signals are
systematically disrupted in a skipped exon or introduced into
a constitutive exon. The CI cassette exon is converted into a
constitutive exon by interrupting all three components of the
motif pattern, whereas strong exon skipping results when the
same components are introduced into constitutive exon 6 of
the human SIRT1 splicing reporter. In both contexts, hnRNP
A1 co-expression mediates silencing and hnRNP H mediates
anti-silencing in concert with all three components of the
motif pattern (Figure 11).
In this study, bioinformatics searches show that the
combination of exonic UAGG and 59-splice-site-proximal
GGGG motifs is relatively rare, since only 0.2% of a large
database of human and mouse exons (approximately 200 out
of approximately 96,000) harbor UAGG and GGGG motifs
together in the correct arrangement. Nonetheless, based on
cDNA and EST evidence a signiﬁcantly higher frequency of
exon skipping is associated with the set of 16 exons in which
the motif pattern ( 1 exonic UAGGs and a 59-splice-site-
proximal GGGG) is conserved in the human and mouse
orthologs (see Figure 4). For 14 of the newly identiﬁed exons
we experimentally determined a rate of approximately 57%
exon skipping based on RT-PCR analysis in a variety of
human and mouse tissues (eight of 14, not counting the CI
cassette). We would expect an imperfect correlation between
the presence of the motif pattern and conﬁrmed exon
skipping, since the approximately 8–10 exonic enhancer
motifs in a typical 140 base exon [13,15] may override the
effects of UAGG and GGGG silencer motifs. This may be due
not only to the arrangement of ESE and intronic splicing
enhancer motifs in and around a target exon, but also to
tissue-speciﬁc variations in splicing factors. Evidence was also
shown for an increased association of conﬁrmed exon
skipping events genome-wide with the presence of two or
more conserved exonic UAGGs, as a variation of the original
motif pattern. Our functional analysis showed that the
presence of multiple UAGGs in the same exon was an
important parameter for a predominant exon skipping
pattern.
The question of the relative 59 splice site strengths of those
exons containing or lacking the UAGG and GGGG motif
pattern was also addressed. When the relative splice site
strengths of the two groups were compared using a rank sum
statistical test, no signiﬁcant difference in the distributions
was found. In fact the median score for splice site strength
was found to be higher (9.31) for the group of exons
containing the motifs than for those without (8.68). The close
proximity of the motifs to, or their overlap with, the 59 splice
site, however, remains an unresolved issue. While a detectable
effect of the (intronic) position of the GGGG motif was
observed in the context of the SIRT1 splicing reporter, the
general rules for such position effects were not determined.
GGGG or UAGG motifs in the 59 splice site region may
interfere with base pairing interactions involving U1 and/or
U6 small nuclear RNAs, and these effects may have a high
degree of position dependence.
Numerous ESE motifs have been functionally identiﬁed in
concert with the regulatory roles of SR proteins, but far less is
known about sequence motifs and factors that control
silencing. Evidence for exonic UAG and UAGG motifs has
been previously reported for splicing silencing mechanisms
mediated by hnRNP A1. These include the K-SAM exon of
human FGFR2 [35], SMN2 exon 7 (UAGACA) [36], HIV Tat
exon 2 (UAGACU) [37,38], CD44 exon v5 (UAGACA) [39],
protein 4.1 exon 16 [40], c-src exon N1 (UAG:GAGGAAGGU)
[41], and exons in the hnRNP A1 transcript itself (UAG and
UAGAGU) [24,42]. Taken together with structural evidence
that hnRNP A1 recognizes TAGG motifs directly [43], A1 is a
likely mediator of many if not all of these silencing events. In
contrast to the previous studies, however, the 59-splice-site-
proximal GGGG motif is a novel and integral component of
the silencing mechanism of the CI cassette exon. While the
silencing effect of the GGGG motif by itself is slight, its
function with exonic UAGGs is synergistic. Our computa-
tional analysis using the CodonShufﬂe algorithm extends
these previous studies by showing genome-wide that the
UAGG motif is signiﬁcantly underrepresented in constitutive
exons and overrepresented in skipped exons. Because the
CodonShufﬂe analysis forbids in-frame UAG stop codons,
these results are in good agreement with the idea that exonic
UAGG motifs function widely as splicing silencers.
In previous studies guanosine-rich motifs have been shown
Figure 9. Exons Identified by Bioinformatics to Contain UAGG and GGGG
Motif Patterns: Analysis of Splicing Patterns in a Heterologous Context
and Effects of hnRNP Co-Expression
Exons were cloned from mouse genomic DNA with 12 nucleotides of
ﬂanking intron sequence on each side. Each fragment was inserted
into the SIRT1a context between the NdeI and XbaI restriction sites
(Test Exon). SIRT1a is identical to SIRT1 except for the NdeI and
XbaI sites located 12 nucleotides upstream and downstream of the
middle exon, respectively. The segment between the NdeI and XbaI
restriction sites represents the region of SIRT1a replaced by test
exons. ESS19a is the same as ESS19 except for the presence of the
indicated restriction sites. Test exons included the CI cassette exon of
rat GRIN1 (GRIN1_CI), exon 8 of MEN1 (MEN1_8), and exon 2 of
Hp1bp3 (Hp1bp3_2). Splicing reporters were expressed in C2C12
cells in the presence of vector backbone (vbb), or with hnRNPA1 or
hnRNPH protein expression vector at a ratio of 1:4. Exon-included
(double arrowheads) and exon-skipped (single arrowheads) mRNA
products were quantiﬁed from the gel shown, and used to calculate
the percent exon included values (top right).
DOI: 10.1371/journal.pbio.0030158.g009
PLoS Biology | www.plosbiology.org May 2005 | Volume 3 | Issue 5 | e158 0855
Exon Silencing by UAGG and GGGG Motifsto regulate splicing in diverse ways. Guanosine triplets are
generally enriched in short mammalian introns [44,45], and
these sequences have been shown to enhance inclusion of an
unusually small exon of cardiac troponin T [46,47], as well as
additional exons of human a-globin [48] and chicken b-
tropomyosin [49], transcripts. Moreover, a disease-related point
mutation in a guanosine cluster at position 26 of the intron
has been shown to disrupt the normal pattern of splicing of
the human pyruvate dehydrogenase E1a transcript [50]. In some
cases, hnRNP H has been implicated in splicing control
together with guanosine-rich sequences. A guanosine-rich
ESS in b-tropomyosin exon 7 is required for exon skipping, and
the degree of hnRNP H binding correlates with exon 7
skipping [51]. The c-src transcript contains a complex intronic
enhancer downstream of the neuron-speciﬁc NI exon in
which multiple guanosine-rich tracts are found that bind to
hnRNP H and F and that are required for normal patterns of
NI exon inclusion [52,53,54]. In addition, hnRNP H has been
shown to bind to the 59 splice site of NF-1 exon 3, where it is
thought to induce exon skipping when the splice site is
weakened by a guanosine to cytosine mutation at positionþ5
of the intron [55]. In this study we show that hnRNP H has a
positive effect on exon inclusion for three unrelated exons
harboring the UAGG and GGGG motif pattern in the context
Figure 10. Computational Analysis of Exonic UAGG Motifs and Exon Skipping Patterns Genome-Wide
Computational searches were performed to identify exons with two or more UAGGs and to determine the association of conﬁrmed exon
skipping events with this group. Exons with a single UAGG were analyzed for comparison. The following constraints were applied: (1) exon
lengths of 250 bases or fewer and (2) both UAGG motifs conserved in sequence and position in the orthologous mouse exons. The graph
illustrates the percentage of conﬁrmed exon skipping events associated with one UAGG or two or more UAGGs (blue bars), or with the
remaining exons lacking these motifs (red bars). The list of 16 human exons identiﬁed with two or more UAGGs is shown with the Ensembl ID,
exon number, 59 splice site sequence, and gene name. It is not unexpected to ﬁnd exon 19 of the glutamate NMDA receptor GRIN1 and exon 13
of NCOA2, which have a 59-splice-site-proximal GGGG, since the sequence of the 59 splice site was not speciﬁed in the search.
DOI: 10.1371/journal.pbio.0030158.g010
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Exon Silencing by UAGG and GGGG Motifsof a heterologous splicing reporter. Because these exons have
no other sequence relatedness, these results suggest that
antagonism with hnRNP A1 might be a frequent property of
hnRNP H in this type of silencing mechanism (see Figure 9).
Model for Splicing Regulation Mediated by a UAGG and
GGGG Code: Differential Roles of hnRNP A1 and H
A full understanding of CI cassette exon regulation will
require explanations for the complex spatial and temporal
variations observed in vivo. Based on functional evidence, we
proposed in a previous study that NAPOR/CUGBP2 enhances
CI exon inclusion in the rat forebrain, where its expression is
enriched. It would be reasonable to predict, however, that the
CI cassette exon is inherently a strong exon and should not
require a positive regulator, since its splice sites match well to
consensus sequences. Here we conﬁrmed this prediction by
experimental manipulations of the UAGG and GGGG motif
pattern that converted the CI cassette exon into a con-
stitutive exon in the absence of NAPOR/CUGBP2 (splicing
reporter T8; see Figure 2). These results clearly demonstrate
differential roles of hnRNP A1 and H proteins. Furthermore,
we showed that the mechanism by which these proteins
regulate the CI cassette can be controlled locally through
sequences in the exon and adjacent 59 splice site independent
of any distal downstream intron sequences from the GRIN1
transcript.
Six ESE motifs within the CI cassette exon were function-
ally identiﬁed in this study, and a seventh, an ASF/SF2 motif,
overlaps with the exon position 93 UAGG silencer (see Figure
11). Predominant exon skipping was retained even when both
of the natural UAGGs were carefully repositioned in the exon
without destroying or creating any known ESEs. That is, in
two distinct cell lines, the six functional ESE motifs did not
overpower the silencing function of the three-part UAGG
and GGGG code. We observed that UAGG motifs are
embedded in 32 ESE motifs reported in the ESEFinder
database [56], suggesting that the occurrence of overlapping
ESE and ESS signals might be quite frequent. In the case of
the CI cassette exon, such an arrangement of opposing
splicing signals would predict that competition between ASF/
SF2 and hnRNP A1 may provide additional options to ﬁne-
tune splicing patterns in different tissues or stages of
development. However, in comparison to hnRNP H, the co-
expression of an ASF/SF2 expression plasmid had only a mild
positive effect on exon inclusion in the cell lines tested (K. H.
and P. J. G., unpublished data).
Here we show evidence for combinatorial regulation by
two different types of RNA elements (UAGG and GGGG)
together with differential roles of hnRNP A1 and H (and F),
but not all of the combinatorial interactions were exper-
imentally deﬁned. Although the intronic GGGG motif and A1
are involved in silencing, site-speciﬁc UV crosslinking of A1
to the GGGG motif was not observed (K. H. and P. J. G.,
unpublished data). This may be due to limitations of the
assay, since UV crosslinking of A1 to its high-afﬁnity site is
inefﬁcient [30]. Alternatively, the intronic GGGG may play a
structural role, or contact an additional protein factor
involved in the assembly of the putative silencing complex.
We speculate that a silencing complex is formed by the
interactions of hnRNP A1 monomers with individual UAGG
and GGGG sites together with cooperative interactions
between these monomers. We also speculate that hnRNP H
and, to a lesser extent, F function principally as anti-silencing
factors in the CI cassette mechanism by binding to the GGGG
and/or UAGG motifs in a way that disrupts the cooperative
binding of A1. In our view this is the simplest model to
account for our experimental results, but more complex
mechanisms cannot be ruled out at this point. Future studies
will be required to establish how the various isoforms of
hnRNP H carry out anti-silencing, and whether accessory
factors are involved.
Substantial evidence exists in support of models involving
competition between hnRNP A1 and SR proteins in
modulating 59 splice site selection or exon inclusion
[24,57,58,59,60,61]. The involvement of hnRNP A1 in the CI
cassette mechanism is also consistent with previous demon-
strations of the cooperative binding of hnRNP A1 to pre-
mRNAs [62,63,64,65]. Based on the analysis of microarray
data [66,67] documenting considerable variations in the
ratios of hnRNP A1 transcripts to hnRNP F and H transcripts
in human and mouse [33], we suggest that such variations may
be involved in directing tissue speciﬁcity of exons that are
regulated by UAGG and GGGG motifs.
Implications of Genome-Wide Analysis
Since the CI cassette exon skipping pattern of the GRIN1
transcript is brain-region-speciﬁc, we wished to determine
the splicing characteristics of other exons with a similar
arrangement of these motifs in the human and mouse
genomes. Other transcripts harboring skipped exons that
were identiﬁed by bioinformatics searches, however, were
found to be involved in a variety of cellular functions, such as
RNA processing, chromatin structure/function, cell signaling,
and regulation of transcription. These include hnRNP H1
and H3 (HNRPH1 and HNRPH3), menin (MEN1), nuclear
Figure 11. Model for Differential Regulation of the CI Cassette Exon by
the Interplay of hnRNP A1 and H and a Ternary Motif Pattern
At the top is a schematic of intron/exon structure and prominent
splicing patterns observed in the forebrain (top) and hindbrain
(bottom) of rat brain. Below is a summary of splicing regulatory
motifs functionally deﬁned in this study depicted on an expanded
version of the GRIN1 CI cassette exon (yellow). ESEs are indicated
above the exon. Nucleotides complementary to U1 small nuclear
RNA and the interaction of the positive regulator NAPOR/CUGBP2
with the downstream intron are indicated (z; as determined in [26]).
UAGG and GGGG splicing silencing motifs deﬁned in this study are
highlighted in red. The working model for splicing silencing, based
on the results shown here, proposes that the CI cassette is a strong
exon silenced by a combination of two exonic UAGG motifs and a 59-
splice-site-proximal GGGG. HnRNP A1 mediates silencing and
hnRNP H mediates anti-silencing via these RNA signals.
DOI: 10.1371/journal.pbio.0030158.g011
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Exon Silencing by UAGG and GGGG Motifsreceptor co-activator 2 (NCOA2), heterochromatin protein 1
binding protein 3 (Hp1bp3), and an uncharacterized hypo-
thalamus transcript (Table 1). A high proportion of the exon
skipping patterns identiﬁed were found to be tissue-speciﬁc.
The observation that exon 5 of HNRPH1 and exon 3 of
HNRPH3 contain conserved UAGG and GGGG motifs is
intriguing, since hnRNP H proteins crosslink speciﬁcally to
the GGGG motif adjacent to the CI cassette exon. These exon
skipping patterns were conﬁrmed by RT-PCR analysis in this
study, and there is additional supporting cDNA and EST
evidence in the databases. The RT-PCR analysis shows that
these exon skipping patterns are relatively weak, but this is
consistent with a motif pattern containing a single exonic
UAGG and 59 splice site GGGG motif. Skipping of exon 5 of
HNRPH1 or exon 3 of HNRPH3 would result in a shift in the
reading frame and introduction of a premature termination
codon. Thus, silencing of these exons at the level of splicing is
expected to reduce protein expression via either nonsense-
mediated mRNA decay or premature termination of protein
synthesis. The results shown here suggest a model in which
hnRNP H proteins may provide a buffering effect against
negative control by hnRNP A1. Autoregulation by a negative
feedback loop was recently demonstrated for the splicing
factor PTB, which induces skipping of the 11th exon of its
cognate pre-mRNA [68]. Similarly, hnRNP A1, SRp20, SC35,
TIA1, and TIAR proteins are all involved in mechanisms that
regulate the splicing patterns of their cognate transcripts
[69,70].
Prospects
If alternative splicing events are as prevalent as recent
studies suggest [21,22,71,72], it will be important to under-
stand on a global scale the biochemical language that
determines tissue-speciﬁc patterns, and tunes these patterns
in response to physiological stimuli [73,74]. Here we show
that UAGG and GGGG motifs function in combination to
silence the CI cassette exon and also serve more generally as
patterns to recognize other skipped exons in the human and
mouse genomes. Combinatorial splicing control mechanisms
are not well understood, and previous studies have not
addressed the brain-region-speciﬁc splicing switch that is
characteristic of the CI cassette exon. Our results suggest
that, in general, it might be a useful strategy to use motif
pattern searches, together with information about spatial
constraints, to identify co-regulated exons. The observation
that UAGG and GGGG motif patterns are generally
predictive of exon skipping may also be useful in interpret-
ing the effects of mutations underlying certain genetic
diseases. Future work will be needed to more fully under-
stand the roles of hnRNP proteins in this type of silencing
(and anti-silencing) mechanism, and to further advance the
understanding of the complex biochemical language re-
sponsible for the regulation and coordination of splicing
events genome-wide.
Materials and Methods
Plasmid construction and mutagenesis. All splicing reporter
plasmids except for those in the experiments of Figure 3D were
derived from the parent plasmid wt (previously called E21wt), in
which the CI cassette exon is ﬂanked by full-length introns and
adjacent exons [26]. Site-directed mutations were introduced into the
CI cassette exon or downstream intron using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, California, United
States), and mutations were conﬁrmed by DNA sequencing. The
splicing reporters wt and wt0 are identical except that wt has a point
mutation at position 78 (C to G change) of the CI exon, which creates
a XhoI site. Chimeric splicing reporters were derived from parent
plasmid rGc25 [75], in which the CI cassette exon and 164 and 103 bp
of the ﬂanking introns (upstream and downstream, respectively) were
introduced as a NotI-BamHI fragment. The full-length upstream
intron was introduced by replacing the XbaI-NotI fragment of rGcCI-
wt0 with the XbaI-NotI PCR product containing GRIN1 exon 18 and
1,092 bp of adjacent intron (plasmid, rGcCI-up). The full-length
downstream intron was introduced by replacing the BamHI-EcoRI
fragment of rGcCI-wt0 with the BamHI-EcoRI fragment containing
GRIN1 exon 20 and 1,810 bp of adjacent upstream intron. All splicing
reporter plasmids were constructed in a pBS vector followed by
transfer into the vector pBPSVPAþ[76], in which expression is driven
by the SV40 promoter. Expression plasmids for hnRNP proteins F, H,
and A1 were generated by subcloning the complete open reading
frames into the BamHI site of pcDNA4/HisMax vector (Invitrogen,
Carlsbad, California, United States). Open reading frames were
obtained from the following plasmids: hnRNP F from plasmid pFlag-F
[53], hnRNP H/H9 from pFlag-DSEF-1 [77,78], and hnRNP A1 from
plasmid Myc-A1 [79]. All plasmid constructs were conﬁrmed by DNA
sequencing, and protein expression was veriﬁed by Western blot
analysis.
Transient expression and analysis of RNA splicing patterns.
Growth of C2C12 cells, transfection, and RT-PCR analysis were
performed as described [26]. Brieﬂy, transfections were performed in
60-mm plates at approximately 70% cell conﬂuency using Lipofect-
amine (Invitrogen). Transfections contained 3.5 lg of total plasmid
DNA made up of splicing reporter plasmid with empty vector and/or
protein expression plasmid at the DNA ratios speciﬁed. PC12 cells
were grown to approximately 85% conﬂuency in RPMI1640
supplemented with 10% fetal bovine serum and 5% horse serum
on poly-D-lysine-coated six-well plates. PC12 cell transfections were
carried out with Lipofectamine 2000 and a total of 1.25 lg of plasmid
DNA (0.25 lg of splicing reporter and 1 lg of protein expression
plasmid or vector backbone). After 48 h, cells (C2C12 and PC12) were
harvested and total RNA was puriﬁed, DNase I treated, and ethanol
precipitated. For analysis of splicing patterns, 1 lg of RNA was
reverse transcribed with random hexanucleotide primers, and 1/20th
of the reaction volume was then ampliﬁed for 20–24 PCR cycles in a
10-ll reaction containing 0.2 lM speciﬁc primers, two units of Taq
polymerase, 0.2 mM dNTPs, and 1 lCi of [a
32P]dCTP in reaction
buffer. Under these conditions approximately 1% of the C residues in
each product molecule are radiolabeled. Primers used to amplify the
CI-cassette-exon-included and -skipped mRNA products were spe-
ciﬁc for the ﬂanking exons. Sequences from Ensembl were used to
design primers for the experiments of Figure 4. Primer sequences are
available upon request. For gel analysis, 25% v/v of each PCR reaction
was resolved on 6% polyacrylamide/5 M urea sequencing gels.
Electrophoresis was performed for 1 h at 30 W. Gel images were
obtained and results quantitated using a Fuji (Tokyo, Japan) Medical
Systems BAS-2500 phosphorimager and Science 2003 ImageGauge
software. For the experiment of Figure 6, PCR reaction products were
resolved on 1% agarose gels in 13 TBE buffer.
Transcription and site-speciﬁc RNA labeling. Radioactive RNA
substrates were prepared for UV crosslinking analysis as follows.
RNAs containing the GGGG motif were prepared by in vitro
transcription in 25-ll reactions containing T7 RNA polymerase, 0.4
mM each of ATP, UTP, and CTP, and 0.3 mM GTP plus 25 lCi of
[a
32P]GTP, 0.5 mM GpppG, and 0.1 lg of DNA template in standard
T7 reaction buffer. DNA templates were prepared by annealing
complementary oligonucleotides with the top strand containing the
T7 promoter sequence at its 59 end, followed by the RNA test
sequence; bottom strands were complementary to the test sequence.
RNAs were puriﬁed after DNase treatment by Sephadex G25
chromatography, phenol extraction, and ethanol precipitation. Site-
speciﬁc labeling of RNA substrates containing the exonic UAGG
motif was performed essentially as described [80]. Transcription
(nonradioactive) of the downstream RNA half was performed as
above except that reactions were larger (125 ll) and contained 2 mM
guanosine instead of GpppG. After gel puriﬁcation, the 59 end of the
downstream-half RNA was labeled by polynucleotide kinase with 25
pmol of the puriﬁed RNA and 25 pmol of [c
32P]ATP (6,000 Ci/mmol).
After removal of ATP by Sephadex G25 chromatography, the
upstream and downstream RNA halves were annealed to a comple-
mentary DNA splint covering 16 bases on either side of the desired
ligation position. Ligation reactions were performed in 10-ll
reactions with 15 Weiss Units of T4 DNA ligase for 4 h at 16 8C,
followed by DNase treatment and gel puriﬁcation. The concentra-
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electrophoresis on 10% polyacrylamide/7M urea gels.
UV crosslinking and immunoprecipitation analysis. UV cross-
linking reactions (12.5 ll) were performed under splicing conditions
as described [81] with 100,000 dpm radiolabeled RNA transcript and
HeLa nuclear extract (4 mg/ml ﬁnal concentration). Following UV
treatment, samples were digested to completion with RNase A (1 mg/
ml, 20 min at 30 8C), and held on ice for immunoprecipitation or
SDS-PAGE analysis. For immunoprecipitation reactions, 25 llo f
protein A beads (Sigma, St. Louis, Missouri, United States) were
equilibrated in Buffer A (10 mM Tris/HCl [pH 7.5], 100 mM NaCl, and
1% TritonX100), and antibody was bound to the beads for 1 h on ice
(5 ll of R7263 or R7264 for analysis of hnRNP F and H, respectively
[82], or 1 ll of 9H10 for analysis of hnRNP A1). Equivalent
concentrations of rabbit preimmune serum or puriﬁed mouse IgG
were used for control reactions. Antibody beads were washed three
times with Buffer A, and added to UV crosslinking reactions (25 ll)
for 20 min on ice. Bound samples were washed four times with Buffer
A, and centrifuged to separate pellet and supernatant. Each reaction
component was boiled in SDS sample buffer, and resolved on
discontinuous 12.5% polyacrylamide gels.
Generation of datasets and computational analysis. Human and
mouse genes that were annotated as orthologs were obtained from
Ensembl release 16 (http://www.ensembl.org). Human–mouse exons
were aligned by BLAST (requiring percent identity  85 and bit score
 20), and genes were checked for consistency in terms of orthologous
exon order. A total of approximately 94,000 conserved human–mouse
exons were retained for further analysis (http://genes.mit.edu/
burgelab/Supplementary/han04). In a separate analysis, approxi-
mately 14,600 internal exons from human genes were designated as
skipped exons based on stringent alignments of cDNA and EST
sequences to cDNA-veriﬁed genomic loci using the genome annota-
tion script GENOA (http://genes.mit.edu/genoa). Mapping these exons
to the conserved human–mouse Ensembl set identiﬁed 4,455 skipped
internal human exons that are conserved in mouse. For the codon
shufﬂing analysis, the ﬁrst 30 bases and the last 60 bases of the
original sequences were removed prior to shufﬂing to simulate
removal of the ﬁrst and last exons. Each sequence was shufﬂed 50
times using the CodonShufﬂe program [32]. The number of
occurrences of each oligonucleotide, e.g., UAGG, divided by the
number of occurrences of all possible oligonucleotides of equal
length, was compared to the corresponding frequency of occurrence
in the shufﬂed sets. The ﬁnal fold underrepresentation was computed
by taking the mean of the fractions computed over the shufﬂed sets,
and dividing by the observed (true) fraction. The p-value for the
reduced occurrence of UAGG in authentic coding sequences was
determined by counting the number of 4-mers that were greater than
1.488-fold reduced relative to the average of 100 shufﬂes. None were
found for each of the ten shufﬂes. Thus the p-value is 0/256, or p ,
0.001.
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